Bronchodilator treatment for asthma and COPD


Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD
Session: Bronchodilator treatment for asthma and COPD
Session type: Thematic Poster Session
Number: 5092
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Bronchodilator treatment for asthma and COPD. Eur Respir J 2010; 36: Suppl. 54, 5092

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020


Bronchodilator reversibility - differences between asthma and COPD
Source: International Congress 2019 – Respiratory function assessment in disease
Year: 2019


Nebulized therapy in bronchial asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 52s
Year: 2002

Adhesion to inhaled treatment in patients with asthma and COPD
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020


Bronchodilator responsiveness in patients with COPD
Source: Eur Respir J 2008; 31: 742-750
Year: 2008



Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Pharmacologic treatment of exacerbations of COPD
Source: International Congress 2016 – Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline
Year: 2016


Exacerbations of asthma and treatment
Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2018


Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 146s
Year: 2001

Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 283s
Year: 2003

A new budesonide/formoterol inhalation therapy in patients with asthma, COPD and ACOS
Source: International Congress 2017 – Bronchial asthma management
Year: 2017

Exacerbations of asthma and COPD
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017

Exacerbations of asthma and COPD
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018

Exacerbations of asthma and COPD
Source: ERS Skills Course 2016
Year: 2016

Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012


Bronchodilator efficacy of tiotropium in patients with mild COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 616s
Year: 2006

The effect of tiotropium in COPD complicated with asthma
Source: Annual Congress 2007 - New insights into the treatment of COPD
Year: 2007